RecallDepth
Class II Terminated

Bevacizumab 1.25 mg/0.05 mL filled to 0.06 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.

This recall has been terminated (originally issued January 27, 2016).

Company
Pine Pharmaceuticals, Llc
Recall Initiated
November 4, 2015
Posted
January 27, 2016
Recall Number
D-0582-2016
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Tonawanda, NY, United States
Official Source
View on FDA website ↗

Reason for Recall

Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lot #: 1648@7, exp. 12/20/2015; 1428@4, exp. 11/17/2015

More recalls by Pine Pharmaceuticals, Llc

View all recalls by this company →

Other recent Class II Drug recalls